School of Systems Biology, National Center for Biodefense and Infectious Diseases, George Mason University, 10650 Pyramid Place, Manassas, VA 20110, United States.
Biochem Biophys Res Commun. 2013 Jan 4;430(1):125-30. doi: 10.1016/j.bbrc.2012.11.042. Epub 2012 Nov 23.
Bacillus anthracis, a causative agent of anthrax, is able to germinate and survive within macrophages. A recent study suggested that B. anthracis-derived nitric oxide (bNO) is a key aspect of bacterial defense that protects bacterial DNA from oxidative burst in the macrophages. However, the virulent effect of bNO in host cells has not been investigated. Here, we report that bNO contributes macrophage killing by S-nitrosylation of bioenergetic-relating proteins within mitochondria. Toxigenic Sterne induces expression of the bnos gene and produces bNO during early stage of infection. Nitroso-proteomic analysis coupled with a biotin-switch technique demonstrated that toxigenic infection induces protein S-nitrosylation in B. anthracis-susceptible RAW264.7. For each target enzyme tested (complex I, complex III and complex IV), infection by B. anthracis Sterne caused enzyme inhibition. Nω-nitro-L-arginine methyl ester, a NO synthase inhibitor, reduced S-nitrosylation and partially restored cell viability evaluated by intracellular ATP levels in macrophages. Our data suggest that bNO leads to energy depletion driven by impaired mitochondrial bioenergetic machinery that ultimately contributes to macrophage death. This novel mechanism of anthrax pathogenesis may offer specific approach to the development of therapeutics.
炭疽杆菌是炭疽病的病原体,能够在巨噬细胞中发芽和存活。最近的一项研究表明,炭疽杆菌衍生的一氧化氮(bNO)是细菌防御的一个关键方面,它可以保护细菌 DNA 免受巨噬细胞中氧化爆发的影响。然而,bNO 在宿主细胞中的毒力作用尚未得到研究。在这里,我们报告 bNO 通过线粒体中与生物能量相关的蛋白质的 S-亚硝基化作用促进巨噬细胞的杀伤。产毒的Sterne 在感染早期诱导 bnos 基因的表达并产生 bNO。硝基蛋白质组学分析结合生物素转移技术表明,产毒感染诱导 B. anthracis 易感 RAW264.7 中的蛋白质 S-亚硝基化。对于测试的每种靶酶(复合物 I、复合物 III 和复合物 IV),炭疽杆菌 Sterne 的感染都会导致酶抑制。NO 合酶抑制剂 Nω-硝基-L-精氨酸甲酯降低了 S-亚硝基化,并通过巨噬细胞内 ATP 水平部分恢复了细胞活力。我们的数据表明,bNO 导致线粒体生物能量机制受损,从而导致能量耗竭,最终导致巨噬细胞死亡。这种炭疽病发病机制的新机制可能为治疗方法的开发提供特定的方法。